We investigated the frequency of the noncardiac findings in cardiac imaging with multidetector computed tomography (MDCT). BACKGROUND Multidetector computed tomography is an accepted new tool to evaluate the heart. In cardiac MDCT scans, organs other than the heart are also irradiated, but usually not assessed.
Multidetector computed tomography (MDCT) with high temporal and spatial resolution is emerging as a noninvasive diagnostic technique to visualize the heart. It is now accepted as a useful modality to detect coronary stenoses (1-10) and coronary plaques (11) , to assess calcification of the coronary arteries (12) , remodeling of coronary atherosclerotic lesions (13) , anatomy of the pericardium (14) , and size and function of the ventricles (15, 16) . Because of the growing number of scanners, these examinations will be
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performed with increasing frequency. This versatile modality is expected to diagnose not only coronary artery disease but also other diseases causing chest pain such as aortic dissection (17, 18) and pulmonary embolism (19, 20) . As all chest organs including portions of the great vessels, lungs, chest wall, spine, liver, and gall bladder are also irradiated during the cardiac MDCT scans, noncardiac diseases unrelated to chest symptoms might be detected. However, the incidence of abnormal findings in these organs in cardiac MDCT has not been fully investigated.
We examined the frequency of noncardiac findings in a series of patients undergoing cardiac MDCT. As to the patients with significant noncardiac findings, we reviewed how these findings were followed up in the 6 months after cardiac MDCT.
METHODS
The study group consisted of 503 consecutive patients with suspected coronary artery disease who underwent diagnostic Patients were scanned in the supine position from the level of the pulmonary arteries through the base of the heart. Patients with a history of coronary artery bypass graft (internal mammary artery or gastroepiploic artery) were scanned widely from the level of the subclavian arteries through the level of the celiac trunk. According to previous reports (4,10), we performed a non-enhanced scan primarily for calcium scoring and an enhanced scan for MDCT angiogram. A contrast-enhanced scan was obtained using 60 to 100 ml of contrast injected through the antecubital vein at 4.5 ml/s, followed by a 30-ml saline chaser. The scan parameters in the 16-MDCT scanner were: 16 ϫ 0.75 mm collimation; rotation time 370 ms, table feed 3.0 mm/ rotation; tube voltage 120 mV; effective mA 550. The scan parameters in the 64-MDCT scanner were: 32 ϫ 0.6 mm collimation; rotation time 330 ms, table feed 3.8 mm/ rotation; tube voltage 120 mV; effective mA 770. Enhanced datasets were reconstructed for assessment of coronary stenosis at Ϫ320 to Ϫ420 ms before the R-wave, and adjusted individually so that the end of the reconstruction period was positioned at the peak of the P-wave on the electrocardiogram (21) .
One dataset was reconstructed with a small field of view (FOV) tightly confined around the heart. A second dataset was reconstructed with a large FOV to include the entire chest in each cross section with a slice thickness of 5 mm. Analysis. All scans were at first analyzed by 3 cardiologists. Images with a large FOV were reviewed by 4 experienced radiologists in standard mediastinal windows (350 W/50C) and lung windows (1,400 W/Ϫ600C). All abnormalities and patients with significant abnormal findings were identified. The number of new noncardiac findings in each organ was counted, and significant findings were defined as abnormalities that required additional follow-up or further investigation. Medical records were reviewed to check the clinical follow-up, subsequent imagings, or surgical procedures of noncardiac abnormalities in the 6 months after cardiac MDCT.
RESULTS
Clinical characteristics of the patients are summarized in Table 1 . There was no evidence of acute coronary syndrome. A total of 420 patients (83.5%) were symptomatic. Sixtyfive patients (12.9%) were current smokers, and 197 patients (39.2%) were former smokers.
In the cardiac analysis, 238 patients (47.3%) had a positive result for cardiac disease. In the noncardiac analysis, a total of 346 noncardiac findings were identified in 292 (58.1%) of 503 patients. Table 2 presents the organs and structures with noncardiac findings. Of 420 symptomatic patients, cardiac disease was detected in 219 patients. Of the remaining 201 patients, 32 patients were diagnosed with noncardiac findings, which could be the cause of symptoms.
A total of 114 patients (22.7%) had significant noncardiac pathology requiring clinical or radiological follow-up. Seventy-five patients underwent further imaging or investigations, and 18 patients had therapeutic consequences during 6 months of follow-up. Table 3 shows the number of patients with diagnostic and therapeutic consequences. Of the other 39 patients, 26 patients were followed without any imaging workup. Follow-up information could not be obtained from outside hospitals in 12 patients. One patient died from brain hemorrhage, which was unrelated to the noncardiac findings.
Imaging workup included 24 computed tomography (CT) scans, 2 magnetic resonance imaging examinations, 2 mammograms, 3 sonograms, and 43 conventional radiographs. The time between cardiac MDCT and follow-up imaging studies ranged from 1 to 178 days.
Malignancies were revealed in 4 patients (0.80%). Two were found to have adenocarcinoma of the lung (Fig. 1) . Both patients were treated surgically. The other 2 patients had malignancy of the breast. One was diagnosed as intraductal carcinoma of the breast (Fig. 2) and surgically treated. The other proved to be angiosarcoma, and the patient died from repetitive hemorrhage of the malignancy.
DISCUSSION
In this study, we found that 58.1% of the patients referred for cardiac MDCT scan had noncardiac findings, 22.7% of the patients were found to have significant noncardiac pathology requiring additional work-up, and 3.6% had therapeutic consequences. During 6 months of clinical follow-up, 4 cases of malignant disease were revealed.
Routine cardiac MDCT is performed by scanning the heart from bifurcation of the pulmonary artery to the left ventricular apex with or without a non-enhanced scan for assessment of calcification. Consequently, images are reconstructed to focus on the heart in synchronization with the diastolic phase. In the process, we can freely adjust the FOV-the area in which a raster with a predefined number of pixels is arranged from the raw data-without additional radiation exposure, because the entire content within the boundaries of the gantry is scanned and available. For cardiac imaging, FOV was confined to be as small as possible to achieve best resolution and ranged from 16 to 25 cm 2 . These images included little of the lung or the other chest organs, although all chest organs were irradiated.
Besides images for cardiac analysis, we made another set of images with a large FOV to evaluate the peripheral chest. This method is not universal, but we think it could be beneficial to evaluate all organs irradiated in the scan. For patients with chest symptoms, pleural or aortic diseases could be differentiated in the same scan. Of 201 symptomatic patients in whom coronary artery disease was ruled out, 32 patients were diagnosed to have noncardiac findings, which could cause anginal symptoms. In these patients, further diagnostic imaging workup was not necessary. In addition, asymptomatic malignancies could be detected. In this study, 3 cases of malignancies were revealed in an asymptomatic and surgically treatable stage. If the peripheral chest had not been properly evaluated in cardiac findings that required clinical or radiological follow-up were observed in 7.8%. In contrast, the present study identified significant noncardiac findings in 22.7%, in which pulmonary nodules and aortic disease were observed more frequently. The higher incidence of pulmonary nodules in our cohort is partly related to a larger number of former or current smokers. Fifty-two percent of the patients were former or current smokers in our study, while only 25% were former or current smokers in the study by Horton et al. (22) . The risk of coronary artery disease decreases promptly after smoking cessation (24) , while the risk of lung carcinoma does not. The incidence of lung cancer correlates with the amount of cigarettes smoked (25) . Therefore, our cohorts were considered to be at a higher risk of lung carcinoma. Contrast enhancement may have contributed to frequent detection of aortic disease in our study, while Horton et al. (22) performed EBCT scans without contrast. Furthermore, the high resolution of MDCT may allow accurate interpretation of pathology in the other chest organs.
Our study detected 2 cases of lung cancer (0.4%) with 6 months of follow-up. In studies of CT screening for lung cancer, frequency of noncalcified nodules in baseline screening ranges from 12% to 46%, that of lung cancer ranges from 0.4% to 2.7% (26 -31). Nawa et al. (28) reported that 0.44% of the patients undergoing low-dose spiral CT scan demonstrated lung cancer and that 26.8% had non-calcified pulmonary nodules in a population quite similar to ours. The population of that study included 62% who were former or current smokers, while our population included 53%. The prevalence of lung cancer in that study (0.44%) was the same as in our study (0.4%).
The limitations of our study are as follows. First, the time of clinical follow-up was relatively short. For example, the only way to make certain that a pulmonary nodule is benign is to follow it up to demonstrate stability over years unless it is surgically resected. We might have underestimated the significance of the noncardiac findings. Second, a cost/ efficacy analysis was not performed in the present study. A prospective, controlled study is necessary to elucidate cost/ efficacy of evaluating noncardiac findings in cardiac MDCT.
In conclusion, a number of clinically significant noncardiac findings might have been missed in conventional cardiac MDCT scans. Although a small percent of the findings resulted in therapeutic consequences, some were important, including asymptomatic malignancies. Cardiologists are familiar with anatomy of the heart but are usually not trained to perform radiological diagnosis of the other thoracic organs. For a cardiologist analyzing cardiac MDCT scans, it is essential to collaborate with radiologists to avoid missing significant findings. Physicians who analyze cardiac MDCT scans-either radiologists or cardiologists-should carefully evaluate all the organs in the scan. Onuma et al. July 18, 2006:402-6 Noncardiac Findings in Cardiac MDCT
